BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19112390)

  • 41. Drug insight: Primary medical therapy of acromegaly.
    Katznelson L
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
    Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological options in the treatment of acromegaly.
    Ezzat S
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transsphenoidal surgery for pituitary adenoma in elderly patients.
    Sheehan JM; Douds GL; Hill K; Farace E
    Acta Neurochir (Wien); 2008 Jun; 150(6):571-4; discussion 574. PubMed ID: 18414774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is insulin growth factor-1 (IGF-1) playing a role for aneurysm formation in patients with pituitary gland tumor?
    Kulseng B; Myhre HO
    Int Angiol; 2006 Dec; 25(4):433-5. PubMed ID: 17164753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Consensus on the change of criteria for cure of acromegaly during the last decade].
    Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
    Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of acromegaly].
    Quabbe HJ
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1060-3. PubMed ID: 7084073
    [No Abstract]   [Full Text] [Related]  

  • 48. Chiasma syndrome in acromegalic patients--correlation of neuroradiologic and neuroophthalmologic findings.
    Gnjidić Z; Iveković R; Rumboldt Z; Malenica M; Vizner B; Berković M
    Coll Antropol; 2002 Dec; 26(2):601-8. PubMed ID: 12528288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A patient with acromegalic heart disease--a case report].
    Hashimoto K; Yamanaka M; Uchida H; Saito Y; Kosaka Y
    Masui; 1997 Jul; 46(7):951-4. PubMed ID: 9251511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resolution of diabetes mellitus but not acromegaly in a cat with a pituitary macroadenoma treated with hypofractionated radiation.
    Littler RM; Polton GA; Brearley MJ
    J Small Anim Pract; 2006 Jul; 47(7):392-5. PubMed ID: 16842276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
    Sesmilo G; Webb SM;
    Endocrinol Nutr; 2010 Feb; 57(2):39-42. PubMed ID: 20189894
    [No Abstract]   [Full Text] [Related]  

  • 52. Controversy: radiotherapy for acromegaly.
    Thorner MO
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):136-7. PubMed ID: 12580926
    [No Abstract]   [Full Text] [Related]  

  • 53. Adolescent acromegaly and decreased arterial distensibility despite successful treatment.
    Bassareo PP; Marras AR; Mercuro G
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):79-85. PubMed ID: 22182355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there still a role for radiotherapy in acromegaly?
    Monson JP
    Neuroendocrinology; 2006; 83(3-4):269-73. PubMed ID: 17047393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy.
    Zhang F; Chen J; Lu Y; Ding X
    J Clin Neurosci; 2009 Oct; 16(10):1273-5. PubMed ID: 19577475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Important points in diagnosis and therapy: acromegaly].
    Ikuyama S; Nawata H
    Nihon Naika Gakkai Zasshi; 1994 Dec; 83(12):2058-63. PubMed ID: 7876693
    [No Abstract]   [Full Text] [Related]  

  • 57. A short acute octreotide test for response prediction of long-term treatment with somatostatin analogues in acromegalic patients.
    Halperin I; Nicolau J; Casamitjana R; Sesmilo G; Serra-Prat M; Palomera E; Puig-Domingo M
    Horm Metab Res; 2008 Jun; 40(6):422-6. PubMed ID: 18393173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the efficacy of Octreotide LAR in the treatment of acromegaly--a yearly observation].
    Bałdys-Waligórska A; Gołkowski F; Krzentowska A; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(5):218-21. PubMed ID: 19739577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endocrine function in the late period after radiation therapy of acromegaly].
    Avakian MR; Marova EI; Kurpatovskaia LE
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (5):32-4. PubMed ID: 2556879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost of clinical management of acromegaly in Spain.
    Roset M; Merino-Montero S; Luque-Ramírez M; Webb SM; López-Mondéjar P; Salinas I; Soto A; Bernal C; Villabona C; De Luis D; Donnay S; Pascual H; Pérez-Luis J;
    Clin Drug Investig; 2012 Apr; 32(4):235-45. PubMed ID: 22397307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.